InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Core Points - InspireMD, Inc. has approved inducement grants of 197,167 shares of restricted stock to five new non-executive employees as part of its compensation strategy [1][2] - The inducement grants are intended to attract individuals who were not previously employees of InspireMD, in compliance with Nasdaq Listing Rule 5635(c)(4) [2] - The restricted stock will vest over a three-year period, with one-third vesting on the first anniversary and the remainder vesting in two equal installments on the second and third anniversaries, contingent on continued employment [3] Company Overview - InspireMD, Inc. focuses on utilizing its proprietary MicroNet® technology to establish its products as the industry standard for carotid stenting, aiming for excellent acute results and long-term stroke-free outcomes [4] - The company's common stock is traded on Nasdaq under the ticker symbol NSPR [4]